Effect of Montelukast on Basophils, In-vitro

Creighton University

Status: Unknown

Conditions: Allergic Rhinitis; Allergic Asthma

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00710450

Townley Merck

Details and patient eligibility

About

Subjects with either allergic asthma or allergic rhinitis will be recruited to obtain blood. This blood will be used to be stimulated with to whatever the patient allergic. In the laboratory, this stimulated blood will be measured for histamine, leukotrienes, IL-13 and IL-3. These are chemicals responsible for allergy symptoms.

Enrollment: 15 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Allergic asthma or allergic rhinitis
• age 12+

Exclusion criteria

• smokers

Trial design

15 participants in 2 patient groups

1

Description:

Allergic Asthma

2

Description:

Allergic Rhinitis